Advancing insulin therapy in T2DM: Emerging dynamics among parameters affecting tight glycemic control

被引：0

|

作者：

Johnson, Mary

Powers, Margaret A.

Hollander, Priscilla

Vlajnic, Aleksandra

Bergenstal, Richard

机构：

来源：

DIABETES | 2007年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A556 / A556

页数：1

相关论文

共 50 条

[41] Personality, Self-Management Behaviors, and Glycemic Control among Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
Morikawa, Sakiko Y.
Fujihara, Kazuya
Hatta, Mariko
Takeda, Yasunaga
Ishii, Dai
Yachida, Junko
Horikawa, Chika
Kato, Mitsutoshi
Maegawa, Hiroshi
Sone, Hirohito
DIABETES, 2019, 68
[42] Poor Glycemic Control among T2DM Patients with Pre-Existing Macrovascular Comorbidities: A Matched Cohort Study
Fu, Alex Z.
Qiu, Ying
Radican, Larry
Yin, Donald
Mavros, Panagiotis
DIABETES, 2009, 58 : A554 - A554
[43] Islet GLUT2 Plasticity Improves Glycemic Control in Insulin-Resistant KK Mice but Not T2DM KKAy Mice
Lepard, Kathy J.
Sondgeroth, Korie L.
DIABETES, 2020, 69
[44] AGE OF DIABETES ONSET: GLYCEMIC CONTROL AND HYPOGLYCEMIA BENEFIT WITH NEW INSULIN GLARGINE 300U/ML IN T2DM
Twigg, S.
Khunti, K.
Forst, T.
Janez, A.
Merino-Trigo, A.
Stella, P.
Grisoni, M. L.
Galstyan, G.
DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A45 - A45
[45] COST-EFFECTIVENESS CONSEQUENCES OF OBESITY IN T2DM BY INSULIN ANALOGUE THERAPY
Jozsa, Z.
Toth, E.
Nagy, B.
VALUE IN HEALTH, 2010, 13 (07) : A289 - A289
[46] Patterns of oral antihyperglycemic therapy and status level of glycemic control among patients with Type 2 diabetes mellitus (T2DM) managed at general hospitals in Korea
Baik, Sei Hyun
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S70 - S71
[47] Effect of pioglitazone on vascular reactivity is associated with improved insulin resistance and lipid metabolism, but not glycemic control, in Mexican Americans with T2DM
Wajcberg, Estela
Fernandez, Marianella
Defronzo, Ralph A.
Cersosimo, Eugenio
DIABETES, 2006, 55 : A145 - A146
[48] Optimal glycemic control with insulin detemir and aspart improves lipoprotein composition and particle number/size in poorly controlled T2DM
Kumar, Pratima
Wang, Shaoyun
Balas, Bogdana
Darland, Celia
Walz, Barbara
Johnson, Lisa
Mathew, Manoj
Cusi, Kenneth
DIABETES, 2008, 57 : A254 - A255
[49] Adherence to Insulin Therapy Assistance Program (iTAP) among Indian Type 2 Diabetes Mellitus (T2DM) Patients
Raj, Praveen
Pawar, Dilip
Jabeen, Sarah
Shivaram, V. S.
DIABETES, 2018, 67
[50] Empagliflozin as Add-On to Basal Insulin for 78 Weeks Improves Glycemic Control With Weight Loss in Insulin-Treated Type 2 Diabetes (T2DM)
Rosenstock, Julio
Jelaska, Ante
Wang, Fei
Kim, Gabriel
Broedl, Uli C.
Woerle, Hans J.
DIABETES, 2013, 62 : A285 - A285

← 1 2 3 4 5 →